Senescence vaccine - Hervolution
Alternative Names: HERV-K and HERV-W immune therapy - HervolutionLatest Information Update: 06 Mar 2024
At a glance
- Originator Unknown
- Class Virus-like particle vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Research Unspecified